Ap­peals court sides with As­traZeneca, BMS, McKesson in saxagliptin heart fail­ure case

Last year
Pharma
Law

Sage 'en­cour­aged' by ini­tial Zurzu­vae sales in post­par­tum de­pres­sion, but no word on ma­jor de­pres­sion plans

Last year
Pharma

SEC, DOJ sub­poe­na Bio­gen over Aduhelm launch and for­eign busi­ness op­er­a­tions

Last year
Pharma

Law­mak­ers’ ex­plo­sive charges turn a glob­al spot­light on Chi­na’s WuXi, and it’s feel­ing the heat

Last year
Bioregnum
China

Mer­ri­mack to dis­solve af­ter record­ing $225M mile­stone; Co­gen­t's $225M place­ment

Last year
News Briefing

In clash over sci­ence and na­tion­al se­cu­ri­ty, Chi­nese ri­val to Il­lu­mi­na strug­gles with US ex­pan­sion

Last year
China
In Focus

Two SPAC’d biotechs raise ad­di­tion­al mon­ey as Bi­hua Chen’s blank check clos­es $184M IPO

Last year
Financing
Cell/Gene Tx

We just had a string of suc­cess­ful biotech IPOs. Now what?

Last year
Bioregnum

Repli­cate Bio­science takes aim at mono-caus­ing virus af­ter promis­ing re­sults with mR­NA ra­bies shot

Last year
R&D

Ahead of share­hold­er vote on SQZ as­set sale and liq­ui­da­tion, founder Ar­mon Sharei says he will vote yes

Last year
People
R&D

Lati­go, a pain biotech years in the mak­ing, emerges with $135M on heels of Ver­tex PhI­II suc­cess

Last year
Financing
Startups

Eu­ro­pean in­vestor Early­bird Health clos­es $185M fund to back 12 to 15 com­pa­nies

Last year
Financing
Startups

In­cyte is 'op­ti­mistic' about skin dis­ease drug Opzelu­ra as pre­scrip­tions grow 77% in Q4

Last year
Pharma

FDA ap­proves Ipsen’s Onivyde as first-line treat­ment for type of pan­cre­at­ic can­cer

Last year
Pharma
FDA+

Law­mak­ers call for US in­ves­ti­ga­tion of Chi­nese con­tract re­search gi­ants

Last year
Pharma
Manufacturing

FDA de­lays PDU­FA date for Rock­et’s rare white blood cell dis­or­der gene ther­a­py

Last year
FDA+
Manufacturing

Mar­ket­ingRx roundup: Pfiz­er, Astel­las' Su­per Bowl spots; Lil­ly de­buts new Alzheimer’s ad

Last year
Pharma
Marketing

Am­gen dou­bles down on ‘bad’ cho­les­terol aware­ness with new cam­paign, free test­ing

Last year
Pharma
Marketing

Organon shelves con­tra­cep­tive with 'nat­u­ral' es­tro­gen

Last year
Pharma
FDA+

Roivant dis­con­tin­ues blood can­cer pro­gram as it fails to re­vive old Ei­sai drug, to dis­solve Hema­vant

Last year
R&D

Lian­Bio to shut­ter, end­ing Shang­hai-based start­up’s transat­lantic am­bi­tions

Last year
People
Startups

The End­points Slack in­ter­view: Zavain Dar on start­ing a new VC, trust­ing the process with the 76ers, and Ap­ple's VR ...

Last year
People
Financing

BMS, Van­tAI team up; CRISPR Ther­a­peu­tics to raise $280M; Ono Phar­ma's deal with Shat­tuck Labs

Last year
News Briefing

Eye­Bio tar­gets reg­is­tra­tional tri­al af­ter ear­ly suc­cess of Wnt ag­o­nist in reti­nal dis­eases

Last year
R&D
First page Previous page 200201202203204205206 Next page Last page
A service from the Financial Times